Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
9.59
-0.14 (-1.44%)
At close: Feb 13, 2026
HKG:2566 Revenue
Hangzhou Jiuyuan Genetic Biopharmaceutical had revenue of 638.78M CNY in the half year ending June 30, 2025, a decrease of -3.71%. This brings the company's revenue in the last twelve months to 1.31B, down -1.56% year-over-year. In the year 2024, Hangzhou Jiuyuan Genetic Biopharmaceutical had annual revenue of 1.37B with 6.35% growth.
Revenue (ttm)
1.31B CNY
Revenue Growth
-1.56%
P/S Ratio
1.62
Revenue / Employee
801.47K CNY
Employees
1,629
Market Cap
2.32B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.37B | 81.78M | 6.35% |
| Dec 31, 2023 | 1.29B | 162.00M | 14.40% |
| Dec 31, 2022 | 1.13B | -181.85M | -13.91% |
| Dec 31, 2021 | 1.31B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition